LoginSignup
APD

BNB Plus Corp.

Stock
Stock
Ticker: APDN
APDN

Price

Price

CHART BY

Frequently asked questions

What is BNB Plus Corp.'s market capitalization?

The market capitalization of BNB Plus Corp. is $12.02M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for BNB Plus Corp.?

BNB Plus Corp.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$921.84. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for BNB Plus Corp.'s stock?

Currently, 1 analysts cover BNB Plus Corp.'s stock, with a consensus target price of $1,125.00. Analyst ratings provide insights into the stock's expected performance.

What is BNB Plus Corp.'s revenue over the trailing twelve months?

Over the trailing twelve months, BNB Plus Corp. reported a revenue of $3.30M.

What is the EBITDA for BNB Plus Corp.?

BNB Plus Corp.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$13.06M. EBITDA measures the company's overall financial performance.

What is the free cash flow of BNB Plus Corp.?

BNB Plus Corp. has a free cash flow of -$13.08M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does BNB Plus Corp. have, and what sector and industry does it belong to?

BNB Plus Corp. employs approximately 48 people. It operates in the Materials sector, specifically within the Biotechnology industry.

What is the free float of BNB Plus Corp.'s shares?

The free float of BNB Plus Corp. is 4.34M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$12.02M
EPS (TTM) 
-$921.84
Free Float 
4.34M
Revenue (TTM) 
$3.30M
EBITDA (TTM) 
-$13.06M
Free Cashflow (TTM) 
-$13.08M

Pricing

52W span
$2.20$190.80

Analyst Ratings

The price target is $1,125.00 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Employees
48
Industries
Biotechnology
Sector
Materials

Identifier

Primary Ticker
APDN
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin